Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Selective P2X1 Receptor Blockade Modulates Platelet Activati
2026-07-07
This study demonstrates that NF449 is a highly selective antagonist of the platelet P2X1 receptor, providing direct evidence for its role in platelet activation and thrombus formation. The findings support a more nuanced approach to targeting platelet P2 receptors, with implications for developing antithrombotic agents that minimize bleeding risk.
-
Tariquidar (XR9576): Advancing Drug Resistance Research Work
2026-07-07
Tariquidar (XR9576) empowers researchers to dissect and overcome transporter-mediated drug resistance—especially in challenging, high-viscosity tumor models. With best-in-class P-gp inhibition, it enables reproducible, quantifiable workflows that directly address mechanotransduction-driven chemoresistance.
-
Heparin sodium (A5066): Reliable Anticoagulant for Cell-Base
2026-07-06
This article provides bench scientists with scenario-driven guidance on leveraging Heparin sodium (SKU A5066) as a reproducible, high-performance glycosaminoglycan anticoagulant. Integrating evidence-based answers from real lab situations, it demonstrates how Heparin sodium from APExBIO optimizes assay consistency, workflow safety, and data interpretation in coagulation and cell viability experiments.
-
Bufuralol Hydrochloride: Advancing β-Adrenergic Modulation S
2026-07-06
Bufuralol hydrochloride unlocks new frontiers in β-adrenergic receptor research, especially when paired with cutting-edge human organoid models. Its partial intrinsic sympathomimetic activity enables nuanced cardiovascular pharmacology experiments, delivering data-rich, translationally relevant results.
-
Suhuang Antitussive Capsule Suppresses ER Stress and NLRP3 i
2026-07-05
This study reveals that Suhuang antitussive capsule mitigates pulmonary dysfunction in a rat model of cough variant asthma by inhibiting endoplasmic reticulum (ER) stress and downstream NLRP3 inflammasome activation. These mechanistic insights highlight ER stress as a pivotal target for intervention and suggest translational relevance for necroptosis pathway modulation in respiratory disease.
-
Mitochondrial Apoptotic Signaling and Muscle Atrophy in Ovar
2026-07-04
The study by Khajehzadehshoushtar et al. investigates whether mitochondrial-linked apoptotic or necroptotic signaling drives skeletal muscle atrophy during ovarian cancer progression. Their findings reveal that while caspase-9 and -3 activities are elevated and responsive to antioxidant intervention, muscle atrophy persists, challenging the causality between mitochondrial apoptosis and atrophy in this context.
-
Z-IETD-FMK: Advanced Caspase-8 Inhibition for Immune Assays
2026-07-03
Z-IETD-FMK (Benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone) delivers highly specific caspase-8 inhibition, enabling precise modulation of apoptosis and T cell proliferation in advanced immune research. Its robust performance and well-defined workflow integration make it an indispensable tool for dissecting NF-κB signaling and TRAIL-mediated apoptosis in both standard and complex models.
-
SAG: Mechanistic Insights and Teratogenic Risks in Hedgehog
2026-07-03
Explore the multifaceted role of SAG as a potent Smoothened receptor agonist, with a deep dive into its mechanism, protocol optimization, and teratogenic effects. This article uniquely connects advanced mechanistic understanding to practical assay decisions for developmental and disease modeling research.
-
Vernakalant Hydrochloride: Precision Workflows in Rapid AF C
2026-07-02
Vernakalant Hydrochloride (RSD1235) empowers researchers with rapid, atrial-selective conversion of atrial fibrillation, delivering quantifiable efficacy and reproducibility in both in vitro and in vivo settings. This guide details actionable protocols, advanced applications, and troubleshooting strategies using APExBIO’s rigorously validated compound.
-
Propranolol: Applied Workflows for Essential Tremor and Beyo
2026-07-02
Propranolol, a non-selective β-adrenergic receptor blocker, is central to research on essential tremor, cardiovascular regulation, and emotional memory modulation. This article delivers actionable protocols, advanced troubleshooting, and insight into the latest neurophysiological findings—translating deep mechanistic understanding into reliable experimental results.
-
Superoxide Dismutase (SOD) Activity Assay Kit: Technical Gui
2026-07-01
The Superoxide Dismutase (SOD) Activity Assay Kit (SKU: K2035) enables researchers to quantitatively assess SOD enzyme activity in biological fluids, supporting studies of oxidative stress and antioxidative defense. This kit is intended for research use only and is not suitable for diagnostic or clinical applications.
-
Trolox in Organoid and Disease Modeling: Advanced Antioxidan
2026-07-01
Explore how Trolox, a water-soluble vitamin E analogue, enables robust oxidative injury and organoid modeling beyond standard antioxidant assays. This article reveals new research and practical guidance for leveraging Trolox as a precision tool in cutting-edge biomedical studies.
-
Merbromin Selectively Inhibits SARS-CoV-2 3CLpro: Mechanisti
2026-06-30
The referenced study identifies merbromin as a mixed-type and selective inhibitor of the SARS-CoV-2 main protease 3CLpro, sparing major proteases such as Proteinase K. This finding advances the mechanistic understanding of protease inhibitor selectivity and provides a basis for targeted antiviral drug design.
-
Mitochondrial Apoptosis and Muscle Atrophy in Ovarian Cancer
2026-06-30
This study dissected the contributions of mitochondrial-linked apoptosis and necroptosis to skeletal muscle atrophy during ovarian cancer progression in a mouse model. While mitochondrial ROS-driven caspase activation was attenuated by SkQ1, muscle atrophy persisted, indicating that neither mitochondrial apoptosis nor necroptosis are primary drivers of type II B muscle fiber loss in this setting.
-
Griseofulvin as a Precision Probe for Mitotic Error Pathways
2026-06-29
Explore how Griseofulvin, a microtubule associated inhibitor, enables advanced research into mitotic error pathways and fungal cell mitosis inhibition. This article reveals novel assay strategies and scientific insights not covered elsewhere.